Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olaf Heidenreich

Showing results (51-60 of 98) with videos related to

Pageof 10
Sort By:
Cell Reports|April 21, 2021
Isoform-specific and signaling-dependent propagation of acute myeloid leukemia by Wilms tumor 1Sandeep Potluri, Salam A Assi, Paulynn S Chin, et al.
EMBO Molecular Medicine|December 12, 2012
Acute B lymphoblastic leukaemia-propagating cells are present at high frequency in diverse lymphoblast populationsKlaus Rehe, Kerrie Wilson, Simon Bomken, et al.
ACS Nano|April 23, 2013
Molecular parameters of siRNA--cell penetrating peptide nanocomplexes for efficient cellular deliveryAlexander H van Asbeck, Andrea Beyerle, Hesta McNeill, et al.
Haematologica|March 7, 2020
Phase II-like murine trial identifies synergy between dexamethasone and dasatinib in T-cell acute lymphoblastic leukemiaYuzhe Shi, Melanie C Beckett, Helen J Blair, et al.
Haematologica|October 5, 2023
Susceptibility of pediatric acute lymphoblastic leukemia to STAT3 inhibition depends on p53 inductionLuca Gasparoli, Clemence Virely, Alexia Tsakaneli, et al.
Blood|January 29, 2021
Venetoclax and dexamethasone synergize with inotuzumab ozogamicin-induced DNA damage signaling in B-lineage ALLHanna Kirchhoff, Uemran Karsli, Caroline Schoenherr, et al.
Cell Reports|May 25, 2017
RUNX1-ETO and RUNX1-EVI1 Differentially Reprogram the Chromatin Landscape in t(8;21) and t(3;21) AMLJustin Loke, Salam A Assi, Maria Rosaria Imperato, et al.
Leukemia|December 15, 2018
Optimized induction of mitochondrial apoptosis for chemotherapy-free treatment of BCR-ABL+acute lymphoblastic leukemiaMichaela Scherr, Hanna Kirchhoff, Karin Battmer, et al.
Frontiers in Immunology|November 1, 2023
Case Report: Immune dysregulation associated with long-lasting regression of a (pre)leukemic cloneJoost B Koedijk, Thomas B van Beek, Marijn A Vermeulen, et al.
Clinical and Translational Medicine|June 22, 2022
Direct targeted therapy for MLL-fusion-driven high-risk acute leukaemiasSandra Cantilena, Luca Gasparoli, Deepali Pal, et al.
Pageof 10

Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Cell Reports|April 21, 2021
Isoform-specific and signaling-dependent propagation of acute myeloid leukemia by Wilms tumor 1Sandeep Potluri, Salam A Assi, Paulynn S Chin, et al.
EMBO Molecular Medicine|December 12, 2012
Acute B lymphoblastic leukaemia-propagating cells are present at high frequency in diverse lymphoblast populationsKlaus Rehe, Kerrie Wilson, Simon Bomken, et al.
ACS Nano|April 23, 2013
Molecular parameters of siRNA--cell penetrating peptide nanocomplexes for efficient cellular deliveryAlexander H van Asbeck, Andrea Beyerle, Hesta McNeill, et al.
Haematologica|March 7, 2020
Phase II-like murine trial identifies synergy between dexamethasone and dasatinib in T-cell acute lymphoblastic leukemiaYuzhe Shi, Melanie C Beckett, Helen J Blair, et al.
Haematologica|October 5, 2023
Susceptibility of pediatric acute lymphoblastic leukemia to STAT3 inhibition depends on p53 inductionLuca Gasparoli, Clemence Virely, Alexia Tsakaneli, et al.
Blood|January 29, 2021
Venetoclax and dexamethasone synergize with inotuzumab ozogamicin-induced DNA damage signaling in B-lineage ALLHanna Kirchhoff, Uemran Karsli, Caroline Schoenherr, et al.
Cell Reports|May 25, 2017
RUNX1-ETO and RUNX1-EVI1 Differentially Reprogram the Chromatin Landscape in t(8;21) and t(3;21) AMLJustin Loke, Salam A Assi, Maria Rosaria Imperato, et al.
Leukemia|December 15, 2018
Optimized induction of mitochondrial apoptosis for chemotherapy-free treatment of BCR-ABL+acute lymphoblastic leukemiaMichaela Scherr, Hanna Kirchhoff, Karin Battmer, et al.
Frontiers in Immunology|November 1, 2023
Case Report: Immune dysregulation associated with long-lasting regression of a (pre)leukemic cloneJoost B Koedijk, Thomas B van Beek, Marijn A Vermeulen, et al.
Clinical and Translational Medicine|June 22, 2022
Direct targeted therapy for MLL-fusion-driven high-risk acute leukaemiasSandra Cantilena, Luca Gasparoli, Deepali Pal, et al.
Pageof 10